Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

BBNX

Beta Bionics Inc

Feb 21 • 04:00PM ET

20.57

Dollar change -0.30
Percentage change -1.44	%

Healthcare • Medical Devices • USA • NASD

Held by: VTI VXF VTWO VTWG VTWV

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	19.13%	Shs Outstand	42.86M	Perf Week	-5.43%
Market Cap	891.30M	Forward P/E	-	EPS next Y	-	Insider Trans	14.24%	Shs Float	35.04M	Perf Month	-
Income	-	PEG	-	EPS next Q	-1.53	Inst Own	38.04%	Short Float	0.60%	Perf Quarter	-
Sales	-	P/S	-	EPS this Y	-	Inst Trans	5.62%	Short Ratio	0.26	Perf Half Y	-
Book/sh	-5.34	P/B	-	EPS next Y	-	ROA	-	Short Interest	0.21M	Perf Year	-
Cash/sh	1.41	P/C	14.64	EPS next 5Y	-	ROE	-	52W Range	20.84 - 24.50	Perf YTD	-12.95%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-16.04%	Beta	-
Dividend TTM	-	Quick Ratio	3.99	Sales past 5Y	6601.12%	Gross Margin	-	52W Low	-1.30%	ATR (14)	1.30
Dividend Ex-Date	-	Current Ratio	4.62	EPS Y/Y TTM	-	Oper. Margin	-	RSI (14)	-	Volatility	3.31% -
Employees	277	Debt/Eq	0.22	Sales Y/Y TTM	-	Profit Margin	-	Recom	2.00	Target Price	25.50
Option/Short	No / Yes	LT Debt/Eq	0.18	EPS Q/Q	-	Payout	-	Rel Volume	0.26	Prev Close	20.87
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	Nov 27	Avg Volume	808.03K	Price	20.57
SMA20	-8.28%	SMA50	-8.28%	SMA200	-8.28%	Trades		Volume	210,630	Change	-1.44%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-20-25	Initiated	Robert W. Baird	Neutral	$20
Feb-20-25	Initiated	Ladenburg Thalmann	Neutral	$20

Feb-21-25 09:35AM	Palantir initiated, Roku upgraded: Wall Streets top analyst calls (TipRanks)
Jan-31-25 05:56PM	Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
06:34AM	Beta Bionics raises $204M in IPO (MedTech Dive)
Jan-30-25 12:55PM	Beta Bionics raises $204m to kickstart medtech IPO season (Medical Device Network)
Jan-29-25 10:34PM	Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering (GlobeNewswire)

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mensinger Mike	Chief Product Officer	Jan 31 '25	Buy	17.00	33,350	566,950	59,019	Feb 03 08:30 PM
Mensinger Mike	Chief Product Officer	Jan 31 '25	Sale	17.00	13	221	25,669	Feb 03 08:30 PM
Wellington Hadley Harbor Aggre	10% Owner	Jan 31 '25	Buy	17.00	1,000,000	17,000,000	3,901,599	Feb 03 04:49 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BBNX

Beta Bionics Inc

Upgrade your FINVIZ experience